Propofol might best be known as the anesthetic Michael Jackson used inappropriately as a sleeping aid. Administered properly, the drug widely is used in hospitals to sedate patients. It also happens to be part of an industrywide drug shortage affecting hospitals throughout the country. Injectable drugs maker Hospira (NYSE:HSP) is among the dwindling number of […]
The impact of drug shortages that have left doctors and patients scrambling for life-saving drugs became much more personal and real today at a U. S. Food and Drug Administration news conference. Nebraska mother Sara Stuckey spoke at the event on behalf of her 6 -year-old son Nate, who needs a leukemia drug to survive. […]
Healthcare is drowning in chaos—from scattered data to burnout-inducing tasks. Discover how smarter workflows and real-time insights can rescue care teams and transform patient outcomes.
Hospira‘s (NYSE:HSP) beleaguered Rocky Mount, North Carolina manufacturing facility has been a drag on the company’s production and its 2011 financial results, and by the looks of the company’s 2012 guidance, the site will operate below capacity for the foreseeable future as Hospira works to regain regulatory compliance. Given the extent of the problems at […]
Hospira (NYSE:HSP) completed a two-year “restructuring and optimization plan” this year that the company expressly stated would increase shareholder value by generating annualized savings between $110 million and $140 million. But now the company faces a phalanx of angry shareholders claiming the company did not disclose the extent of problems at a North Carolina plant […]
Hospira (NYSE:HSP) plans to spend up to $375 million over the next three years to bring its manufacturing facilities into regulatory compliance, the bulk of it going to a North Carolina plant saddled under heavy regulatory scrutiny for much of the last two years. The effort is under way with a hiring blitz over the […]